Satoshi Fukumoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Satoshi Fukumoto has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Sato
Section of Oral Medicine for Children, Division of Oral Health, Growth and Development, Faculty of Dental Science Kyushu University Fukuoka Japan
9 shared publications- Keiji Masuda
Section of Oral Medicine for Children, Division of Oral Health, Growth and Development, Faculty of Dental Science Kyushu University Fukuoka Japan
8 shared publications - Yuta Chiba
Division of Pediatric Dentistry, Department of Community Social Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
8 shared publications Aya Yamada
Section of Pediatric Dentistry, Division of Oral Health, Growth and Development, Faculty of Dental Science, Kyushu University, Fukuoka, Japan
6 shared publicationsYuta Hirofuji
Section of Oral Medicine for Children, Division of Oral Health, Growth and Development, Faculty of Dental Science Kyushu University Fukuoka Japan
6 shared publicationsShouichi Ohga
Department of Pediatrics, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
5 shared publications
Latest Publications
- Open Access
- 3 April 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (3) , 100781
Corrigendum to ‘Identification of cell type specific marker genes of dental epithelial cells using single cell RNA sequence: a Review’ [J. Oral Biosci. 68, (2026) 100757]
- 3 April 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (3) , 100781
Open AccessCorrigendum to ‘Identification of cell type specific marker genes of dental epithelial cells using single cell RNA sequence: a Review’ [J. Oral Biosci. 68, (2026) 100757]
- Open Access
- 5 March 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (2) , 100766
Spatiotemporal profiling of Fat family genes highlights Fat2 as a novel marker of outer enamel epithelium and stratum intermedium
- 5 March 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (2) , 100766
Open AccessSpatiotemporal profiling of Fat family genes highlights Fat2 as a novel marker of outer enamel epithelium and stratum intermedium
- Open Access
- 16 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71570
MECP2 Insufficiency Attenuates RUNX2 ‐Dependent Osteoblast Differentiation via miR ‐126‐3p/ DKK1 ‐Mediated Canonical Wnt Signaling Inhibition in Rett Syndrome
Rett syndrome (RTT) is a rare neurodevelopmental disorder caused by loss‐of‐function mutations in the gene encoding methyl‐CpG‐binding protein 2 (MECP2) that is located on the X chromosome. Affected individuals also exhibit a variety of non‐neurological symptoms such as kyphoscoliosis and osteoporosis. Thus, MECP2 may play a functional role in bone remodeling and osteoblast differentiation. This study aimed to clarify the molecular mechanisms underlying the deregulation of bone remodeling in RTT. Human deciduous tooth‐derived mesenchymal stem cells that exhibit osteoblast plasticity were used as a cellular model of RTT. Using a small interfering RNA‐mediated MECP2 (MECP2‐siR) knockdown system, we quantitatively analyzed the RUNX2‐dependent and canonical Wnt signaling pathways during osteoblast differentiation. Expression of active β‐catenin, RUNX2, and their downstream targets (osteocalcin and alkaline phosphatase) and mineralization were decreased in MECP2‐siR‐treated osteoblasts compared to that in control osteoblasts. In contrast, the MECP2‐siR‐treated osteoblasts exhibited an increase in the endogenous Wnt antagonist DKK1. Notably, MECP2/DKK1 double‐knockdown osteoblasts possessed greater β‐catenin and RUNX2 levels than MECP2 single‐knockdown osteoblasts. Furthermore, microRNA126‐3p was upregulated in MECP2‐siR‐treated osteoblasts, and an antagomir of microRNA126‐3p prevented DKK1 upregulation, thereby improving the levels of active β‐catenin and other osteoblastic phenotypes. These results suggest that MECP2 insufficiency enhances DKK1 expression via the upregulation of microRNA126‐3p, suppressing the canonical Wnt signaling and subsequent RUNX2‐dependent osteoblast differentiation. The present study provides insights into the molecular mechanisms involved in impaired osteoblast differentiation that contribute to the development of osteoporosis in RTT.
- 16 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71570
Open AccessMECP2 Insufficiency Attenuates RUNX2 ‐Dependent Osteoblast Differentiation via miR ‐126‐3p/ DKK1 ‐Mediated Canonical Wnt Signaling Inhibition in Rett Syndrome
Rett syndrome (RTT) is a rare neurodevelopmental disorder caused by loss‐of‐function mutations in the gene encoding methyl‐CpG‐binding protein 2 (MECP2) that is located on the X chromosome. Affected individuals also exhibit a variety of non‐neurological symptoms such as kyphoscoliosis and osteoporosis. Thus, MECP2 may play a functional role in bone remodeling and osteoblast differentiation. This study aimed to clarify the molecular mechanisms underlying the deregulation of bone remodeling in RTT. Human deciduous tooth‐derived mesenchymal stem cells that exhibit osteoblast plasticity were used as a cellular model of RTT. Using a small interfering RNA‐mediated MECP2 (MECP2‐siR) knockdown system, we quantitatively analyzed the RUNX2‐dependent and canonical Wnt signaling pathways during osteoblast differentiation. Expression of active β‐catenin, RUNX2, and their downstream targets (osteocalcin and alkaline phosphatase) and mineralization were decreased in MECP2‐siR‐treated osteoblasts compared to that in control osteoblasts. In contrast, the MECP2‐siR‐treated osteoblasts exhibited an increase in the endogenous Wnt antagonist DKK1. Notably, MECP2/DKK1 double‐knockdown osteoblasts possessed greater β‐catenin and RUNX2 levels than MECP2 single‐knockdown osteoblasts. Furthermore, microRNA126‐3p was upregulated in MECP2‐siR‐treated osteoblasts, and an antagomir of microRNA126‐3p prevented DKK1 upregulation, thereby improving the levels of active β‐catenin and other osteoblastic phenotypes. These results suggest that MECP2 insufficiency enhances DKK1 expression via the upregulation of microRNA126‐3p, suppressing the canonical Wnt signaling and subsequent RUNX2‐dependent osteoblast differentiation. The present study provides insights into the molecular mechanisms involved in impaired osteoblast differentiation that contribute to the development of osteoporosis in RTT.
- Open Access
- 12 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (2) , 100758
AmeloD regulates cell proliferation and differentiation process of ameloblasts through modulation of the sonic hedgehog (shh) signaling pathway
- 12 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (2) , 100758
Open AccessAmeloD regulates cell proliferation and differentiation process of ameloblasts through modulation of the sonic hedgehog (shh) signaling pathway
- Open Access
- 7 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100757
Identifying cell-type-specific marker genes of dental epithelial cells using single-cell RNA sequence: A review
- 7 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100757
Open AccessIdentifying cell-type-specific marker genes of dental epithelial cells using single-cell RNA sequence: A review
- Open Access
- 24 October 2025
- Published by Springer Nature in Research Square
Hepatocyte growth factor signaling regulates tooth germ development, inducing proliferation of mesenchymal cells via fission of mitochondria
Tooth morphogenesis is regulated by epithelial–mesenchymal interactions and cellular metabolism through intricate signaling pathways. Here, we identify a novel mechanism by which hepatocyte growth factor (HGF) signaling promotes mesenchymal cell proliferation during tooth germ development via the regulation of mitochondrial dynamics. Immunohistochemistry revealed spatiotemporal expression of c-Met, the HGF receptor, in both the epithelial and mesenchymal compartments of developing mouse molars. Organ culture showed recombinant HGF increased tooth germ size and mesenchymal proliferation, whereas the c-Met inhibitor PHA-665752 suppressed these effects. Mitochondrial staining and Western blotting demonstrated that HGF stimulated mitochondrial fission through increased phosphorylation of Drp1, whereas PHA-665752 or Mdivi-1, a Drp1 inhibitor, blocked this response and attenuated proliferation. The inhibition of mitochondrial fission also reduced HGF-induced tooth germ growth ex vivo. HGF activated MAPK pathways, particularly the ERK, p38, and JNK pathways, with JNK inhibition (SP600125) most effectively suppressing Drp1 phosphorylation, defining the HGF-JNK-Drp1 axis as central to this process. Epithelial proliferation was largely unaffected, underscoring a mesenchyme-specific mechanism. These findings reveal a previously unrecognized role of mitochondrial fission as a downstream effector of HGF signaling and highlight mitochondrial dynamics as a potential therapeutic target in developmental anomalies of the dentition.
- 24 October 2025
- Published by Springer Nature in Research Square
Open AccessHepatocyte growth factor signaling regulates tooth germ development, inducing proliferation of mesenchymal cells via fission of mitochondria
Tooth morphogenesis is regulated by epithelial–mesenchymal interactions and cellular metabolism through intricate signaling pathways. Here, we identify a novel mechanism by which hepatocyte growth factor (HGF) signaling promotes mesenchymal cell proliferation during tooth germ development via the regulation of mitochondrial dynamics. Immunohistochemistry revealed spatiotemporal expression of c-Met, the HGF receptor, in both the epithelial and mesenchymal compartments of developing mouse molars. Organ culture showed recombinant HGF increased tooth germ size and mesenchymal proliferation, whereas the c-Met inhibitor PHA-665752 suppressed these effects. Mitochondrial staining and Western blotting demonstrated that HGF stimulated mitochondrial fission through increased phosphorylation of Drp1, whereas PHA-665752 or Mdivi-1, a Drp1 inhibitor, blocked this response and attenuated proliferation. The inhibition of mitochondrial fission also reduced HGF-induced tooth germ growth ex vivo. HGF activated MAPK pathways, particularly the ERK, p38, and JNK pathways, with JNK inhibition (SP600125) most effectively suppressing Drp1 phosphorylation, defining the HGF-JNK-Drp1 axis as central to this process. Epithelial proliferation was largely unaffected, underscoring a mesenchyme-specific mechanism. These findings reveal a previously unrecognized role of mitochondrial fission as a downstream effector of HGF signaling and highlight mitochondrial dynamics as a potential therapeutic target in developmental anomalies of the dentition.
- Open Access
- 25 September 2025
- Published by Elsevier in Archives of Oral Biology
- Vol. 180, 106404
Expression patterns of desmosome family members during tooth development and the role of Desmocollin-3 in cytodifferentiation of stratum intermedium
- 25 September 2025
- Published by Elsevier in Archives of Oral Biology
- Vol. 180, 106404
Open AccessExpression patterns of desmosome family members during tooth development and the role of Desmocollin-3 in cytodifferentiation of stratum intermedium
- Open Access
- 9 April 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (7) , e23608
S100a6 knockdown promotes the differentiation of dental epithelial cells toward the epidermal lineage instead of the odontogenic lineage
Tooth development is a complex process involving various signaling pathways and genes. Recent findings suggest that ion channels and transporters, including the S100 family of calcium‐binding proteins, may be involved in tooth formation. However, our knowledge in this regard is limited. Therefore, this study aimed to investigate the expression of S100 family members and their functions during tooth formation. Tooth germs were extracted from the embryonic and post‐natal mice and the expression of S100a6 was examined. Additionally, the effects of S100a6 knockdown and calcium treatment on S100a6 expression and the proliferation of SF2 cells were examined. Microarrays and single‐cell RNA‐sequencing indicated that S100a6 was highly expressed in ameloblasts. Immunostaining of mouse tooth germs showed that S100a6 was expressed in ameloblasts but not in the undifferentiated dental epithelium. Additionally, S100a6 was localized to the calcification‐forming side in enamel‐forming ameloblasts. Moreover, siRNA‐mediated S100a6 knockdown in ameloblasts reduced intracellular calcium concentration and the expression of ameloblast marker genes, indicating that S100a6 is associated with ameloblast differentiation. Furthermore, S100a6 knockdown inhibited the ERK/PI3K signaling pathway, suppressed ameloblast proliferation, and promoted the differentiation of the dental epithelium toward epidermal lineage. Conclusively, S100a6 knockdown in the dental epithelium suppresses cell proliferation via calcium and intracellular signaling and promotes differentiation of the dental epithelium toward the epidermal lineage.
- 9 April 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (7) , e23608
Open AccessS100a6 knockdown promotes the differentiation of dental epithelial cells toward the epidermal lineage instead of the odontogenic lineage
Tooth development is a complex process involving various signaling pathways and genes. Recent findings suggest that ion channels and transporters, including the S100 family of calcium‐binding proteins, may be involved in tooth formation. However, our knowledge in this regard is limited. Therefore, this study aimed to investigate the expression of S100 family members and their functions during tooth formation. Tooth germs were extracted from the embryonic and post‐natal mice and the expression of S100a6 was examined. Additionally, the effects of S100a6 knockdown and calcium treatment on S100a6 expression and the proliferation of SF2 cells were examined. Microarrays and single‐cell RNA‐sequencing indicated that S100a6 was highly expressed in ameloblasts. Immunostaining of mouse tooth germs showed that S100a6 was expressed in ameloblasts but not in the undifferentiated dental epithelium. Additionally, S100a6 was localized to the calcification‐forming side in enamel‐forming ameloblasts. Moreover, siRNA‐mediated S100a6 knockdown in ameloblasts reduced intracellular calcium concentration and the expression of ameloblast marker genes, indicating that S100a6 is associated with ameloblast differentiation. Furthermore, S100a6 knockdown inhibited the ERK/PI3K signaling pathway, suppressed ameloblast proliferation, and promoted the differentiation of the dental epithelium toward epidermal lineage. Conclusively, S100a6 knockdown in the dental epithelium suppresses cell proliferation via calcium and intracellular signaling and promotes differentiation of the dental epithelium toward the epidermal lineage.
- Open Access
- 11 October 2023
- Published by Wiley in FASEB BioAdvances
- Vol. 5 (12) , 507-520
TRPV4‐mediated Ca2+ deregulation causes mitochondrial dysfunction via the AKT/α‐synuclein pathway in dopaminergic neurons
Mutations in the gene encoding the transient receptor potential vanilloid member 4 (TRPV4), a Ca2+ permeable nonselective cation channel, cause TRPV4‐related disorders. TRPV4 is widely expressed in the brain; however, the pathogenesis underlying TRPV4‐mediated Ca2+ deregulation in neurodevelopment remains unresolved and an effective therapeutic strategy remains to be established. These issues were addressed by isolating mutant dental pulp stem cells from a tooth donated by a child diagnosed with metatropic dysplasia with neurodevelopmental comorbidities caused by a gain‐of‐function TRPV4 mutation, c.1855C > T (p.L619F). The mutation was repaired using CRISPR/Cas9 to generate corrected isogenic stem cells. These stem cells were differentiated into dopaminergic neurons and the pharmacological effects of folic acid were examined. In mutant neurons, constitutively elevated cytosolic Ca2+ augmented AKT‐mediated α‐synuclein (α‐syn) induction, resulting in mitochondrial Ca2+ accumulation and dysfunction. The TRPV4 antagonist, AKT inhibitor, or α‐syn knockdown, normalizes the mitochondrial Ca2+ levels in mutant neurons, suggesting the importance of mutant TRPV4/Ca2+/AKT‐induced α‐syn in mitochondrial Ca2+ accumulation. Folic acid was effective in normalizing mitochondrial Ca2+ levels via the transcriptional repression of α‐syn and improving mitochondrial reactive oxygen species levels, adenosine triphosphate synthesis, and neurite outgrowth of mutant neurons. This study provides new insights into the neuropathological mechanisms underlying TRPV4‐related disorders and related therapeutic strategies.
- 11 October 2023
- Published by Wiley in FASEB BioAdvances
- Vol. 5 (12) , 507-520
Open AccessTRPV4‐mediated Ca2+ deregulation causes mitochondrial dysfunction via the AKT/α‐synuclein pathway in dopaminergic neurons
Mutations in the gene encoding the transient receptor potential vanilloid member 4 (TRPV4), a Ca2+ permeable nonselective cation channel, cause TRPV4‐related disorders. TRPV4 is widely expressed in the brain; however, the pathogenesis underlying TRPV4‐mediated Ca2+ deregulation in neurodevelopment remains unresolved and an effective therapeutic strategy remains to be established. These issues were addressed by isolating mutant dental pulp stem cells from a tooth donated by a child diagnosed with metatropic dysplasia with neurodevelopmental comorbidities caused by a gain‐of‐function TRPV4 mutation, c.1855C > T (p.L619F). The mutation was repaired using CRISPR/Cas9 to generate corrected isogenic stem cells. These stem cells were differentiated into dopaminergic neurons and the pharmacological effects of folic acid were examined. In mutant neurons, constitutively elevated cytosolic Ca2+ augmented AKT‐mediated α‐synuclein (α‐syn) induction, resulting in mitochondrial Ca2+ accumulation and dysfunction. The TRPV4 antagonist, AKT inhibitor, or α‐syn knockdown, normalizes the mitochondrial Ca2+ levels in mutant neurons, suggesting the importance of mutant TRPV4/Ca2+/AKT‐induced α‐syn in mitochondrial Ca2+ accumulation. Folic acid was effective in normalizing mitochondrial Ca2+ levels via the transcriptional repression of α‐syn and improving mitochondrial reactive oxygen species levels, adenosine triphosphate synthesis, and neurite outgrowth of mutant neurons. This study provides new insights into the neuropathological mechanisms underlying TRPV4‐related disorders and related therapeutic strategies.
- Open Access
- 19 September 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 681, 7-12
Effects of melatonin on dopaminergic neuron development via IP3-mediated mitochondrial Ca2+ regulation in autism spectrum disorder
- 19 September 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 681, 7-12
Open AccessEffects of melatonin on dopaminergic neuron development via IP3-mediated mitochondrial Ca2+ regulation in autism spectrum disorder